Titan Pharmaceuticals
TTNP
#10414
Rank
A$9.23 M
Marketcap
A$6.94
Share price
-3.76%
Change (1 day)
20.01%
Change (1 year)

Titan Pharmaceuticals (TTNP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$0.39 Million

According to Titan Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.39 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Titan Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.77 M-63.36%
2023-12-31A$2.11 M-46.48%
2022-12-31A$3.96 M0.53%
2021-12-31A$3.93 M-33.5%
2020-12-31A$5.92 M-48.73%
2019-12-31A$11.55 M12.05%
2018-12-31A$10.31 M0.02%
2017-12-31A$10.3 M35.7%
2016-12-31A$7.59 M-12.11%
2015-12-31A$8.64 M-42.2%
2014-12-31A$14.95 M5.35%
2013-12-31A$14.19 M-69.24%
2012-12-31A$46.14 M56.18%
2011-12-31A$29.54 M177.77%
2010-12-31A$10.63 M142.96%
2009-12-31A$4.37 M
2007-12-31A$4.86 M13.07%
2006-12-31A$4.3 M0.46%
2005-12-31A$4.28 M-9.68%
2004-12-31A$4.74 M5.57%
2003-12-31A$4.49 M-35.81%
2002-12-31A$7 M-38%
2001-12-31A$11.29 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
A$0.20 B 51,284.41%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
A$4.46 M 1,028.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$75.38 M 18,940.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 43,170,622.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.14 B 23,778,227.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
A$1.26 B 319,528.90%๐Ÿ‡บ๐Ÿ‡ธ USA